| The influence of mortality trials on the evolution of clinical practice. | |
| | |
MedLine Citation:
|
PMID: 8062307 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Clinical practice is complex and is influenced by a number of factors such as time since medical qualification, opportunities for further education and peer review, as well as trial results and marketing. Systematic audit and peer review are powerful tools that are being used increasingly. When aided by the intelligent, but not Draconian, use of financial carrots they are an effective means of changing practice. Positive trials, such as those of thrombolytic therapy, have rapidly resulted in the widespread use of such treatment. Negative trials, for example those involving anti-arrhythmic prophylaxis after myocardial infarction or the use of calcium antagonists in patients with impaired left ventricular function, have also correctly resulted in an appropriate change in practice. Advertising does not always reflect best clinical practice and could lead to under-promotion of older but more useful drugs. Peer review and audit are probably the best available methods for promoting good clinical practice. |
| | |
Authors:
|
P Sleight |
Related Documents
:
|
6232847 - Monitoring activity of fibrinolytic agents. a therapeutic challenge. 2662737 - Reperfusion, patency and reocclusion with anistreplase (apsac) in acute myocardial infa... 1797897 - Thrombolytic therapy soon after left heart catheterization--is it safe? 2959717 - Thrombolysis with intravenous human recombinant tissue-type plasminogen activator in ac... 2163757 - Detection of intramyocardial hemorrhage using high-field proton (1h) nuclear magnetic r... 17584277 - Atrio-ventricular block during left atrial flutter ablation. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Cardiology Volume: 84 ISSN: 0008-6312 ISO Abbreviation: Cardiology Publication Date: 1994 |
Date Detail:
|
Created Date: 1994-09-22 Completed Date: 1994-09-22 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 1266406 Medline TA: Cardiology Country: SWITZERLAND |
Other Details:
|
Languages: eng Pagination: 413-9 Citation Subset: IM |
Affiliation:
|
John Radcliffe Hospital, University of Oxford, UK. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiotensin-Converting Enzyme Inhibitors
/
therapeutic use Cardiovascular Diseases / drug therapy*, mortality* Clinical Trials as Topic* Humans Meta-Analysis as Topic Multicenter Studies as Topic Physician's Practice Patterns Thrombolytic Therapy |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Improving patient care: some unresolved issues in heart failure.
Next Document: Improving patient care: consequences for resource allocation.